186 related articles for article (PubMed ID: 34282705)
1. Engineering of hybrid anticancer drug-loaded polymeric nanoparticles delivery system for the treatment and care of lung cancer therapy.
Zhao Y; Liu K; Li J; Liao J; Ma L
Drug Deliv; 2021 Dec; 28(1):1539-1547. PubMed ID: 34282705
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
3. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
Liu D; Zhang W; Liu X; Qiu R
Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of
Zhong T; Liu X; Li H; Zhang J
Drug Deliv; 2021 Dec; 28(1):2108-2118. PubMed ID: 34607478
[TBL] [Abstract][Full Text] [Related]
5. Co-drug delivery of regorafenib and cisplatin with amphiphilic copolymer nanoparticles: enhanced
Zhou Z
Drug Deliv; 2020 Dec; 27(1):1319-1328. PubMed ID: 32936009
[TBL] [Abstract][Full Text] [Related]
6. Chemopreventive Effect of 5-Flurouracil Polymeric Hybrid PLGA-Lecithin Nanoparticles against Colon Dysplasia Model in Mice and Impact on p53 Apoptosis.
A Attia M; Enan ET; Hashish AA; M H El-Kannishy S; Gardouh AR; K Tawfik M; Faisal S; El-Mistekawy A; Salama A; Alomar SY; H Eltrawy A; Yagub Aloyouni S; Zaitone SA
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33467560
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and in vitro evaluation of magnetic nanoparticles modified with PCL-PEG-PCL for controlled delivery of 5FU.
Asadi N; Annabi N; Mostafavi E; Anzabi M; Khalilov R; Saghfi S; Mehrizadeh M; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):938-945. PubMed ID: 29468888
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of 5-fluorouracil and oxaliplatin in novel poly(3-hydroxybutyrate-co-3-hydroxyvalerate acid)/poly(lactic-co-glycolic acid) nanoparticles for colon cancer therapy.
Handali S; Moghimipour E; Rezaei M; Saremy S; Dorkoosh FA
Int J Biol Macromol; 2019 Mar; 124():1299-1311. PubMed ID: 30248424
[TBL] [Abstract][Full Text] [Related]
9. Synergistic induction of apoptosis in lung cancer cells through co-delivery of PLGA phytol/α-bisabolol nanoparticles.
Kiruthiga C; Balan DJ; Prasath NH; Manikandakrishnan M; Jafni S; Prabhu NM; Pandian SK; Devi KP
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5131-5144. PubMed ID: 38240783
[TBL] [Abstract][Full Text] [Related]
10. Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice.
Haggag YA; Osman MA; El-Gizawy SA; Goda AE; Shamloula MM; Faheem AM; McCarron PA
Biomed Pharmacother; 2018 Sep; 105():215-224. PubMed ID: 29857301
[TBL] [Abstract][Full Text] [Related]
11. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
12. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
13. Bypassing pro-survival and resistance mechanisms of autophagy in EGFR-positive lung cancer cells by targeted delivery of 5FU using theranostic Ag
Duman FD; Akkoc Y; Demirci G; Bavili N; Kiraz A; Gozuacik D; Acar HY
J Mater Chem B; 2019 Dec; 7(46):7363-7376. PubMed ID: 31696188
[TBL] [Abstract][Full Text] [Related]
14. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
Yurtdaş-Kırımlıoğlu G; Güleç K; Görgülü Ş; Kıyan HT
Microvasc Res; 2022 Jan; 139():104251. PubMed ID: 34520775
[TBL] [Abstract][Full Text] [Related]
15. Dual-Targeting Nanoparticles: Codelivery of Curcumin and 5-Fluorouracil for Synergistic Treatment of Hepatocarcinoma.
Ni W; Li Z; Liu Z; Ji Y; Wu L; Sun S; Jian X; Gao X
J Pharm Sci; 2019 Mar; 108(3):1284-1295. PubMed ID: 30395829
[TBL] [Abstract][Full Text] [Related]
16. Combined Therapeutic Effects of
Wu P; Zhu H; Zhuang Y; Sun X; Gu N
Int J Nanomedicine; 2020; 15():2777-2787. PubMed ID: 32368054
[TBL] [Abstract][Full Text] [Related]
17. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
18. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
Bhattacharya S
Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
[TBL] [Abstract][Full Text] [Related]
19. Comparative Evaluation of Nimesulide-Loaded Nanoparticles for Anticancer Activity Against Breast Cancer Cells.
Sengel-Turk CT; Hascicek C; Bakar F; Simsek E
AAPS PharmSciTech; 2017 Feb; 18(2):393-403. PubMed ID: 27007742
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
